Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.65%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Revenue | $6.6M | $23.0M | $618.1M | $483.5M | $64.2M |
| Cost of revenue | $0 | $15.0M | $276.5M | $330.0M | $127.1M |
| Gross profit | $6.6M | $8.0M | $341.6M | $153.5M | −$62.9M |
| Gross margin | 100.0% | 34.9% | 55.3% | 31.7% | -97.9% |
| R&D | $21.4M | $28.5M | $42.8M | $171.5M | $150.6M |
| Operating income | −$20.8M | −$45.1M | $190.2M | −$203.6M | −$394.9M |
| EBITDA | −$16.8M | −$39.5M | $166.8M | −$148.3M | −$311.2M |
| Net income | −$20.6M | −$47.4M | $33.1M | −$194.1M | −$373.5M |
| Net margin | -311.0% | -206.3% | 5.4% | -40.1% | -581.5% |
| EPS (diluted) | -0.14 | -0.33 | 0.23 | -1.31 | -2.44 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $162M | $-0.31 | $-0.31–$-0.31 | 1 |
| 2027 | $281M | $-0.13 | $-0.13–$-0.13 | 1 |
Forward consensus · source: Financial Modeling Prep
CUE HEALTH INC
No one on the platform currently holds HLTHQ.
No tracked institution reports a position in HLTHQ as of their last filing.
No one on the platform has traded HLTHQ yet.
| $111 |
| — |
| HTGMQHTG Molecular Diagnostics, Inc. | $0.00 | +0.00% | $221 | — |
| MDVLQMedAvail Holdings, Inc. | $0.00 | +0.00% | $161 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.